Ilika Accelerates Towards EV Battery Commercialisation with Jaguar Land Rover – Baden Hill

Ilika plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Ilika PLC (LON:IKA) is again in the news in the commercialisation of its proprietary solid-state battery (SSB) platform, Goliath, aimed at transforming the electric vehicle (EV) market. The latest announcement marks a pivotal move with the launch of industrial prototyping in collaboration with Jaguar Land Rover (JLR), reinforcing Ilika’s growing position as a leader in next-generation battery technology.

The news comes as Ilika initiates the PRIMED programme, a UK government-backed initiative that builds on its earlier HISTORY and SiSTEM projects. These efforts have already laid the foundation for significant technical progress in Ilika’s Goliath platform. With JLR joining the programme’s steering committee alongside renowned battery expert Professor Paul Shearing from the University of Oxford, Ilika is clearly surrounding itself with the UK’s best automotive and scientific minds.

Dr Tom McColm, Clean Tech Equity Specialist at Baden Hill, noted, “The continued UK government funding and contribution of top-class human and industrial resource into commercialising Ilika’s Goliath SSB platform, demonstrates Ilika establishing itself as the UK flagship for next-generation, high-performance, solid-state battery technology for EV application.”

This phase of development will focus on the production of P2 Goliath prototypes and 50Ah A-sample batteries at the UK Battery Industrialisation Centre (UKBIC), paving a direct path to giga-scale commercial production. Importantly, the initiative benefits from non-dilutive government grant funding and partnerships with industry leaders such as BMW, Agratas, and now JLR.

Ilika’s strategy is not just about innovation—it’s about readiness for real-world application. The company already has evaluation agreements with 17 potential licensing partners, many of them tier-1 global automotive original equipment manufacturers (OEMs). The momentum over the past year has been significant, with clear improvements in both battery performance and manufacturing scalability.

As Dr McColm highlights, “Today’s news is further evidence the program is tracking toward delivering a minimum viable product (‘MVP’) into tier-1 automotive partner hands for evaluation and subsequent licensing in the near-term.”

Despite being pre-revenue at scale, Ilika’s robust financial backing, access to UKBIC, and consistent government support provide a solid foundation for future commercial success. With no dividend paid and earnings per share forecast to remain negative in the near term, the investment thesis centres firmly on growth potential and strategic positioning within the EV supply chain.

On a Final Note

Ilika’s progress with Jaguar Land Rover under the PRIMED programme signals a crucial leap toward the future of battery innovation. By combining government support, academic excellence, and automotive industry involvement, Ilika is advancing its Goliath platform into a commercial reality. The groundwork laid today could shape the future of EV performance tomorrow, as the company aims to deliver safer, longer-lasting, and more efficient batteries at industrial scale.

Share on:
Find more news, interviews, share price & company profile here for:

    If our articles help you then why not add us as a preferred news source on Google.

    Ilika’s Stereax batteries set for Medical Technology Ireland showcase

    Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

    Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

    Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

    Ilika positions solid state batteries for the future of implantable neurostimulation

    Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

    Ilika advances manufacturing readiness for solid-state batteries

    Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

    Ilika reports first Stereax revenues and Goliath progress

    Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

    Search

    Search